Alaya.bio
Pre-clinicalOur nanoparticle enhances the transduction efficiency of quiescent cells like T-cells, NK-cells. Learn More
Founded
2021
Focus
Drug DeliveryNanotechnology
About
Our nanoparticle enhances the transduction efficiency of quiescent cells like T-cells, NK-cells. Learn More
Funding History
1Total raised: $2.1M
Seed$2.1MUndisclosedJan 15, 2023
Company Info
TypePrivate
Founded2021
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile